Literature DB >> 35947143

Lipoxin alleviates oxidative stress: a state-of-the-art review.

You Zhou1,2,3, Chong-Ge You4.   

Abstract

OBJECTIVE: This review aims to summarize the capability of lipoxin in regulating oxidative stress.
BACKGROUND: Oxidative stress is defined as an imbalance between the production of free radicals and the antioxidant system, and it is associated with the existence of a large number of oxidation products, such as reactive oxygen species (ROS) and reaction nitrogen species (RNS), causing damage to human tissues through immunoinflammatory responses. Therefore, reducing oxidative stress is vital to alleviate pathological damage. Lipoxin, an acronym for lipoxygenase interaction product, is a bioactive autacoid metabolite of arachidonic acid made by various cell types. Previous studies have shown that lipoxin is associated with a variety of biological functions, including anti-inflammatory, regulating immune responses, promoting the repair of damaged cells, etc. The deficiency of lipoxin is a critical pathological mechanism in different diseases. Moreover, the ability of lipoxin to attenuate oxidative stress is noteworthy, thereby protecting the human body from diverse diseases.
METHODS: We searched papers from PubMed database using search terms, such as lipoxin, lipoxin A4, oxidative stress, and other relevant terms.
RESULTS: A total of 103 articles published over the past 20 years were identified for inclusion. We summarized the capability of lipoxin in regulating oxidative stress and mechanism.
CONCLUSION: Lipoxin is provided with a protective role in attenuating oxidative stress.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Biological functions; Lipoxin; Oxidative stress; Pathological mechanism

Year:  2022        PMID: 35947143     DOI: 10.1007/s00011-022-01621-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   6.986


  90 in total

Review 1.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

2.  Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.

Authors:  A Planagumà; T Domenech; I Jover; I Ramos; S Sentellas; R Malhotra; M Miralpeix
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

3.  Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression.

Authors:  Nina Kim; Katie L Lannan; Thomas H Thatcher; Stephen J Pollock; Collynn F Woeller; Richard P Phipps
Journal:  J Immunol       Date:  2018-10-22       Impact factor: 5.422

4.  Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production.

Authors:  Carrie D Fischer; Stephanie C Duquette; Bernard S Renaux; Troy D Feener; Douglas W Morck; Morley D Hollenberg; Merlyn J Lucas; Andre G Buret
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

Authors:  Xia Kong; Sheng-Hua Wu; Li Zhang; Xiao-Qing Chen
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

6.  Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice.

Authors:  Marcelo H Petri; Andrés Laguna-Fernandez; Hildur Arnardottir; Craig E Wheelock; Mauro Perretti; Göran K Hansson; Magnus Bäck
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

7.  The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome.

Authors:  Esra Sinem Kemer Doğan; Burak Doğan; Özlem Fentoğlu; Fatma Yeşim Kırzıoğlu
Journal:  J Periodontal Implant Sci       Date:  2019-04-24       Impact factor: 2.614

8.  Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis.

Authors:  Xinxin Liu; Xin Wang; Xiaoru Duan; Devesh Poorun; Juntao Xu; Song Zhang; Lu Gan; Mengwen He; Ke Zhu; Zhangyin Ming; Feng Hu; Hongxiang Chen
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

9.  Anti-Inflammatory Benefits of Antibiotics: Tylvalosin Induces Apoptosis of Porcine Neutrophils and Macrophages, Promotes Efferocytosis, and Inhibits Pro-Inflammatory CXCL-8, IL1α, and LTB4 Production, While Inducing the Release of Pro-Resolving Lipoxin A4 and Resolvin D1.

Authors:  Ruth Moges; Dimitri Desmonts De Lamache; Saman Sajedy; Bernard S Renaux; Morley D Hollenberg; Gregory Muench; Elizabeth M Abbott; Andre G Buret
Journal:  Front Vet Sci       Date:  2018-04-11

10.  Colorectal Cancer Is Associated with a Deficiency of Lipoxin A4, an Endogenous Anti-inflammatory Mediator.

Authors:  Haojing Liu; Ji Zeng; Wei Huang; Qiang Xu; Duyun Ye; Rui Sun; Dongxin Zhang
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.